2013; Haferkamp et al., 2009; Rayess, Wang, & Srivatsan, 2012; Sviderskaya et al., 2003) . Additionally, mutations in CDKN2A seem to reduce nucleotide excision repair capacity and contribute to oxidative stress (Jenkins et al., 2011; Sarkar-Agrawal, Vergilis, Sharpless, DePinho, & Runger, 2004) . The MC1R codes for a G s protein-coupled receptor that is expressed on the cell surface of melanocytes (AbdelMalek et al., 1995 (AbdelMalek et al., , 2014 . Activation of the MC1R by its agonist α-melanocyte-stimulating hormone (α-MSH) stimulates eumelanin synthesis, reduces ultraviolet radiation (UV)-induced generation of reactive oxygen species and enhances DNA repair in human melanocytes (Kadekaro et al., 2010; Song et al., 2009; Swope et al., 2014 ).
An additional mechanism by which the activated MC1R prevents the genotoxic effects of UV is by inhibiting the degradation of the tumor suppressor PTEN, thereby leading to inactivation of the phosphatidylinositol 3 kinase/Akt oncogenic pathway (Cao et al., 2013) .
Multiple epidemiological studies reported that coinheritance of a mutant CDKN2A and MC1R LOF variant exacerbates melanoma risk and results in early onset of melanoma (Box et al., 2001; Demenais et al., 2010; Fargnoli, Gandini, Peris, Maisonneuve, & Raimondi, 2010; Goldstein et al., 2005) . CDKN2A mutation carriers with one MC1R variant showed a double melanoma risk as compared to CDKN2A mutation carriers expressing wild-type MC1R (Fargnoli et al., 2010) . This led us to compare the in vitro behavior of primary human melanocyte cultures established from skin biopsies of members of three familial melanoma kindreds who are carriers of one of three known deleterious CDKN2A mutations, and expressing either wild-type or LOF MC1R variant(s), and of those established from donors expressing wild-type for CDKN2A and similar MC1R genotype (Table 1) . We focused on investigating cultured melanocytes, given that they are the skin cells most drastically affected by CDKN2A mutations or MC1R variants. The endpoints, we examined were: expression of p16, INK4B (p15), and Rb proteins, proliferation rate, capacity for replicative senescence, and various aspects of the DNA damage response to UV. In vitro, melanocytes heterozygous for V126D or 5′UTR-34G>T mutation, even those carrying MC1R LOF allele(s), were similar to their CDKN2A wild-type counterparts in all these parameters. Our results confirm that malignant transformation of CDKN2A mutant and MC1R variant melanocytes requires accumulation of additional "hits", such as somatic mutations in genes that regulate proliferation or apoptosis, as reported (Bennett, 2016) . Expression of MC1R LOF variants increases the chance for somatic mutations that drive melanomagenesis (RoblesEspinoza et al., 2016) . It is also conceivable that CDKN2A germline mutations in keratinocytes and fibroblasts result in an aberrant microenvironment that promotes melanocyte transformation. Our results underscore the importance of investigating the impact of coinheritance of CDKN2A and MC1R mutations on melanocytes in the context of the skin as an organ. We have established from the same cohort primary keratinocyte and fibroblast cultures that we will use to investigate the impact of CDKN2A genotype on their secretome and to develop 3D skin models to address how the cutaneous microenvironment might affect the genomic stability of melanocytes.
| MATERIAL S AND ME THODS

| Establishment of primary melanocyte cultures and UV irradiation
Primary adult human melanocyte cultures were established from skin biopsies of members of familial melanoma kindreds or other patients of the Huntsman Cancer Institute Melanoma Clinic in Utah, after informed consent (IRB protocol; # 7916) . Other cultures were established from surgical discards of adult skin or from neonatal foreskins. All of these cultures were maintained in our previously described routine melanocyte growth medium . However, the cultures 13a and 14a failed to proliferate in this medium, and required a more enriched growth medium in order to replicate, as described earlier (Sviderskaya et al., 2003) . The enriched medium consisted of MCDB 153, 2% fetal bovine serum, 5 μg/ml insulin, 0.5 μg/ml hydrocortisone, 28 μg/ml bovine pituitary extract, 1 nM endothelin-1, and 1 ng/ml basic fibroblast growth factor. The cultures were authenticated by immunostaining for the melanocyte-specific marker TRP-1. Penicillin/streptomycin and antimycotics, as well as plasmocin, were added routinely to the culture media. For experiments involving UV exposure, melanocytes were irradiated with a dose of 75 or 90 mJ/cm 2 UV, as described (Kadekaro et al., 2010) .
| cAMP measurement
The levels of cAMP were determined using a radioimmunoassay, as described (Suzuki, Cone, Im, Nordlund, & Abdel-Malek, 1996) .
| Determination of doubling time
Melanocytes were plated in six-well plates at a density of 0. on day 3. Medium was changed, and cell numbers in the control and UV-irradiated groups were determined on day 3, and every other day thereafter, for 10 more days (n = 3 wells/time point). The doubling times were calculated from the slope of the growth curve.
| Cell cycle analysis
Melanocytes were plated at a density of 0.3 × 10 6 cells/60 mm dish.
On day 3 after plating, cells were irradiated with 0 (control) or 75 mJ/ cm 2 UV, and fresh medium was added thereafter. Cell cycle analysis was performed at 0, 6, 24, 48, and 72 hr after UV as described (von Koschembahr, Swope, Starner, & Abdel-Malek, 2015) .
| β-galactosidase staining
Melanocytes were plated at a density of 2 × 10 4 cells/well in an eightwell chamber slide (4 wells/group). After 3 days, cells were stained using a commercially available kit (Cell Signaling). Microscopic images were acquired, the percent of β-galactosidase-positive melanocytes were quantified, and the data expressed as mean ± SEM. At least, 500 melanocytes were analyzed/group.
| Quantitation of cyclobutane pyrimidine dimers (CPD)
Melanocytes were plated at 0.3 × 10 6 cells/60 mm dish, and irradiated 3 days thereafter with 0 (control) or 90 mJ/cm 2 UV, a dose that results in extensive DNA damage, but moderate apoptosis (≤20%).
At least, triplicate dishes were included in each group. In some experiments, melanocytes were treated with α-MSH prior to, and post UV-irradiation, as described (Kadekaro et al., 2010) . Three, and 48 hr post UV, melanocytes were harvested and fixed, immunostained with CPD-specific antibody (CosmoBio), and analyzed by flow cytometry, as described (Kadekaro et al., 2010) . TA B L E 1 List of primary melanocyte cultures that were established and used in this study
| Measurement of hydrogen peroxide
Melanocytes were plated and irradiated with 90 mJ/cm 2 UV.
Generation of hydrogen peroxide was determined at 0, 30, and 60 min post UV as described (Song et al., 2009 ).
| Western blot analysis
For detection of p16, p15, and phospho (p)-Rb, melanocytes were plated at a density of 0.75-1 × 10 6 cells/100 mm dish. Three days thereafter, fresh medium was added, and 24 hr later, cells were lysed using RIPA buffer containing protease and phosphatase inhibitors.
Western blotted proteins were detected using specific antibodies for p16 or p15 (Abcam, Cambridge, MA), and p-Rb (Cell Signaling, Danvers, MA). For detection of p-and total JNK and p38, p-Rb, p53
and GADD45α, melanocytes were plated as above, irradiated with 0 (control) or 75 mJ/cm 2 UV, and cell lysates prepared at 0.5,1.5, 4, 6, and 24 hr. Phospho-and total JNK and p38 antibodies were purchased from Cell Signaling, and p53 and GADD45α antibodies were obtained from Santa Cruz Biotechnology (Dallas, TX).
| RE SULTS AND D ISCUSS I ON
| Expression of p16, Rb, and p15, and MC1R activity in cultured melanocytes:
We established primary human melanocyte cultures from members of three familial melanoma pedigrees who are heterozygous for the CDKN2A mutation V126D and expressing either wild-type or MC1R LOF variant R151C, R160W, and D294H, or heterozygous for CDKN2A 5′UTR-34G>T or 32ins24 mutation and LOF MC1R variant, or V60L, a variant associated with blonde hair and modest increase in melanoma risk (Box et al., 1997; Kadekaro et al., 2010; Smith et al., 1998) . The CDKN2A V126D mutation in exon 2 creates a temperature-sensitive protein that binds to CDK4 efficiently at the permissive temperature of 34°C (Goldstein et al., 2001; Parry & Peters, 1996) . The 5′UTR-34G>T mutation in exon 1 introduces an alternative translational start site that was reported to reduce expression of the wild-type protein (Liu et al., 1999) . The 32ins24 mutation in exon 1 codes for a protein containing 8 additional amino acids (Eliason et al., 2006) . These mutations are deleterious and do not affect expression of p14 ARF, the second CDKN2A product (Goldstein et al., 2006) . For all experiments, with exception of 13a and 14a, all cultures were maintained in the same routine melanocyte growth medium . Except for very rare cases worldwide, all CDKN2A familial melanoma patients are heterozygous for a CDKN2A mutation, yet the normal allele can be epigenetically silenced, resulting in loss of heterozygosity (Castellano & Parmiani, 1999) . We first investigated the expression of p16 protein, the product of CDKN2A, in the melanocyte cultures at early (≤8) versus late (≥9) passage, to determine the impact of each of the three CDKN2A mutations and possibly LOF MC1R variants, and to rule out epigenetic silencing over time in culture. By Western blot analysis, we detected p16, and p-Rb, the inactive form of Rb, given that p16 activates Rb by inhibiting its phosphorylation, in the panel of melanocyte cultures listed in F I G U R E 1 Detection of p16, p15, and p-Rb in melanocytes with different CDKN2A and MC1R genotypes using Western blot analysis. In (a), p16 and p-Rb were detected in early passage (≤8) cultures. Bands 1a-4a, 7a, 8a, 11a, 12a, 17a, and 18a were detected on the same membrane; 5a, 9a, 10a, and 21a were detected on a second membrane, and 6a, 13a, 14a, and 23a were detected on a third membrane. In (b), p16, p-Rb, and p15 were detected in late passage (≥9) cultures. Actin was used as loading control. +/+ = wild-type; −/− = expression of two mutant CDKN2A alleles; R/+ = heterozygous for a red hair (R) LOF MC1R allele; R/R = homozygous or compound heterozygous for 2 R LOF MC1R alleles; R/r = compound heterozygous for a LOF variant and the moderate V60 allele; p/+ = heterozygous for the pseudoallele V92M MC1R variant (Hmel-16-II) with two mutant CDKN2A alleles (Gruis et al., 1995; Sviderskaya et al., 2003) . As reported earlier, 13a lacked p16, while 14a expressed high p16 levels ( Figure 1 ) (Gruis et al., 1995; Huot et al., 2002) . The remaining cultures expressed p16 at different levels, and CDKN2A 32ins24 mutation carriers 11a and 12a, expressed p16 as two bands, with the higher molecular weight band representing the product of the mutant allele (Figure 1 ). The levels of p16 protein did not correlate with MC1R genotype. Expression of p16 remained detectable in late passage melanocytes (Figure 1b) , which approached replicative senescence, as depicted by marked prolongation of doubling time and increase in the percent of β-galactosidase-positive melanocytes (Figures 2 and 3) . These results suggest that CDKN2A is not epigenetically silenced with increased passage in culture.
The level of p-Rb, which is reduced by p16, varied among the different cultures, possibly due to differences in their proliferation rate, passage number, and overall genetic background ( Figure 1a) . In early passage melanocytes, 24 hr after addition of fresh growth medium, the levels of p-Rb induced by mitogens, and representing inactive Rb, were highest in 3a and 5a, and in p16-null 13a melanocytes ( Figure 1a ). There seemed to be an inverse correlation between p16 and p-Rb levels, particularly in late passage cultures (Figure 1b , Supporting information Figure S1 ). The levels of p-Rb were lowest in late passage cultures 11a, 12a, 14a, 15a, 20a, and 23a with the highest levels of p16, and low or no proliferation capacity, as depicted below in Figures 1b, 2 , 3, and Supporting information Figure S1 . Late passage p16-null 13a also expressed very low levels of p-Rb, possibly due to the inhibitory effect of other cyclin/cdk inhibitors. These results suggest that p16 mutation carriers continue to express functional p16 protein and/or other cyclin/cdk inhibitors with increased passage in culture.
Similar to p16, p15, the product of CDKN2B, adjacent to CDKN2A, functions as a cyclin-D-CDK4/6 inhibitor, and promotes melanocyte senescence (Hannon & Beach, 1994; McNeal et al., 2015) . We examined the levels of p15 in the above melanocyte cultures (Figure 1b ) (McNeal et al., 2015) . The p16-null 13a expressed the highest levels of p15. Densitometry analysis revealed an inverse correlation between p16 and p15 levels in 7 of 20 (35%) cultures, mostly in 15a and 23a followed by 3a, 18a, and 25a, which expressed the highest levels of p16 and low levels of p15, and in 19a and 21a, which expressed very low levels of p16 and relatively high levels of p15 (Supporting information Figure S1 ), suggesting a compensatory role of these two CDK inhibitors.
To elucidate, if CDKN2A mutations might reduce MC1R activity, we measured the increase in the levels of cyclic adenosine monophosphate (cAMP), the second messenger for MC1R, in response to treatment with its agonist α-MSH (Suzuki et al., 1996) .
Melanocytes expressing V126D or 5′UTR-34 > T mutation, even
those coexpressing a LOF MC1R allele, responded to 10 nM α-MSH with significant increase in cAMP levels, which differed among cultures due to donor variability and differential expression of genes that affect MC1R expression or its cAMP pathway, as reported earlier (Supporting information Table S1 ) (Kadekaro et al., 2010) .
We have reported that treatment of melanocytes expressing functional MC1R with α-MSH enhanced their capacity to repair UVinduced CPD, the major form of DNA photoproducts (Kadekaro et al., 2010) . We found that V126D mutant melanocytes, similar to their wild-type counterparts, responded to α-MSH with enhanced repair of UV-induced CPD, further confirming that the CDKN2A mutations investigated did not inhibit MC1R activity (Supporting information Figure S2 ).
| Comparison of population doubling time and capacity for replicative senescence of different melanocyte cultures
Given the significance of p16 as a CDK inhibitor and regulator of senescence, and of MC1R signaling in regulating melanocyte proliferation (Sun et al., 2007; Swope, Medrano, Smalara, & Abdel-Malek, 1995) , we compared the proliferation capacity of the melanocyte cultures as a function of passage in culture by determining their respective doubling times. In general, almost all melanocytes showed gradual reduction in their proliferation rate evidenced by prolonged doubling time with increased passage number (Figure 2 ).
Exceptions were 11a and 12a, coexpressing 32ins24 CDKN2A mutation and a LOF MC1R variant that had the lowest proliferation capacity and longest doubling times even at early passage (5 and 4, respectively) (Figure 2 ), which limited their use for further experiments. In contrast, 21a maintained a high proliferation rate and the same doubling time (4.1 days) at passages 9 and 13 (Figure 2 ).
The doubling time did not seem to correlate with donors' age. For example, at early passages (3-7), the doubling times of 6a and 17a, from donors age 42 and 43 were comparable to those of 8a and 22a, and shorter than that of 18a, from donors in their twenties ( Figure 2 , Table 1 ). The two cultures 13a and 14a, expressing two mutant CDKN2A alleles, failed to proliferate in the routine melanocyte growth medium and required a highly enriched growth medium in order to proliferate, as previously reported (Sviderskaya et al., 2003) . In our enriched medium, the doubling time of 13a increased from 5 days at passage 14 to 16.8 days at passage 21, and that of 14a was maintained at 11.7 days at passages 17 and 20 (Figure 2) . Unfortunately, early passages of these two cultures are not available. As reported (Fung et al., 2013; Sviderskaya et al., 2003) , p16-null 13a exhibited reduction of proliferation rate under highly enriched culture conditions, albeit at a higher passage than their heterozygous or wild-type counterparts, suggesting that p15, and possibly other CDK inhibitors, compensate for p16 loss and drive the senescence program.
The cultures varied in their doubling times independently of CDKN2A or MC1R genotype, with the exception of 11a and 12a (Figure 2 ), and this was corroborated by cell cycle analysis (Supporting information Table S2 ). These variations are due to differential expression of other genes that regulate proliferation rate in different donors. Interestingly, the two wild-type cultures 17a and 18a, but not 15a, underwent a sharp decline in proliferation by passages 7 and 9, respectively. The number of population doublings of the different melanocyte cultures until they became quiescent ranged between a minimum of 8-11 for10a -12a, and 18a, to ≥19 for 2a-8a, 15a, and 21a (Supporting information Table S3 ), which correlated in most cases with their early doubling time. These results suggest that expression of V126D or 5′UTR-34G>T CDN2A mutation, with or without LOF MC1R allele did not have an obvious impact on the proliferative capacity of melanocytes, known to be regulated by the crosstalk of multiple signaling pathways .
Senescence is a state of permanent growth arrest that is reached after cells exhaust their proliferation capacity, and is primarily regulated by p16 in melanocytes (Haferkamp et al., 2009; Sviderskaya et al., 2002) . In light of the results in Figure 2 , we investigated whether the marked reduction in proliferation with passage in culture was due to replicative senescence. For that, we compared the percent of senescent melanocytes at different passages, using β-galactosidase staining (Figure 3 ) (Dimri et al., 1995) . Consistent with the doubling time data (Figure 2 ), the percent of β-galactosidasepositive melanocytes and the intensity of staining increased with passage in culture, regardless of their CDKN2A or MC1R genotype.
An exception was 21a, which had less than 12% of melanocytes positive for β-galactosidase at passage 9 (data not shown), consistent with their persistently high proliferation rate (Figure 2 ). Increased β-galactosidase staining was even evident in 13a and 14a, albeit at a much higher passage than other cultures. The percent of β-galactosidase-positive cells increased by about 30% in 13a and 14a from passages 18 and 17 to passages 22 and 21, respectively, further confirming that other effectors, such as p15 and p21 can compensate for loss of p16 function (Fung et al., 2013; Sviderskaya et al., 2003) .
Even neonatal melanocytes (26n and 29n) showed a remarkable increase in β-galactosidase-positive staining with increased passage (22 and 14, respectively) in culture. We conclude that carriage of mutations in CDKN2A even with coexpression of a MC1R LOF variant does not abrogate replicative senescence or extend the proliferative capacity of melanocytes.
| DNA damage response to UV
Solar UV is a main etiological factor for melanoma, and UV signature mutations are evident in melanoma tumors (Hodis et al., 2012) . The role of MC1R in the UV response of melanocytes is well-documented, and the possible role of p16 in regulating DNA repair has also been reported Cao et al., 2013; Sarkar-Agrawal et al., 2004) . To investigate the DNA damage response to UV of melanocyte cultures with different CDKN2A and MC1R genotypes (in Table 1 ), we compared their responses to irradiation with 75 mJ/cm 2 UV, a sublethal dose that induced substantial DNA photoproducts.
DNA damage induced by UV results in cell cycle arrest to allow for DNA repair (Kastan, Onyekwere, Sidransky, Vogelstein, & Craig, 1991; Lo et al., 2005) . All cultures tested, regardless of genotype, including 13a and 14a, responded to the above UV dose with pro- Table S2 ), suggesting their ability to sense DNA damage.
Since V126D is a common CDKN2A mutation in melanoma-prone families in the United States. (Goldstein et al., 2001) , we further compared the DNA damage response to UV of 4a and 5a to that of 13a, 17a, and 21a, using Western blot analysis for the stressactivated MAP kinases JNK and p38, p53 and its downstream target GADD45α, all known to be activated by UV, and p-Rb, which is inhibited by UV ( Figure 5 , Supporting information Figure S1 ) (Medrano, Im, Yang, & Abdel-Malek, 1995; Smith et al., 1996; Tada, Pereira, Beitner-Johnson, Kavanagh, & Abdel-Malek, 2002) The increase in p-Rb in the unirradiated control groups was markedly less in the late, as compared to early passage cultures, consistent with reduced proliferation in the former (Figure 5b ). These findings demonstrate that mutations in CDKN2A, even complete loss of p16,
do not inhibit the above responses of melanocytes to UV.
The DNA damage response to UV involves activation of DNA repair to maintain genomic stability (Cimprich & Cortez, 2008) . We compared repair of CPDs in 2a, 5a, 7a, 13a, and 16a, and found substantial DNA repair, with only 28%-44% of mean fluorescence of CPDs remaining at 48 hr, as compared to 3 hr post UV (Figure 5d ).
These results further confirm that a mutant CDKN2A allele, even lack of p16 and coexpression of a MC1R LOF variant, does not impair the capacity of melanocytes to repair DNA photoproducts.
Irradiation of melanocytes with UV results in the rapid generation of hydrogen peroxide (Song et al., 2009 ). Previous reports indicated that p16 is critical for reduction of oxidative stress ( (Jenkins et al., 2011) . However, exposure of melanocytes with different CDKN2A
and MC1R genotypes to 90 mJ/cm 2 UV resulted in increased levels of hydrogen peroxide, which reached a maximum at 60 min in all the cultures tested (Supporting information Table S4 ). The variability in basal and UV-induced hydrogen peroxide levels among the cultures with different CDKN2A or MC1R genotype can be attributed to donor variability and differential expression of genes that regulate the antioxidant defenses.
In summary, using primary melanocyte cultures that naturally express a CDKN2A mutation with or without a MC1R LOF allele, and multiple functional assays, we found that these melanocytes do not markedly differ in their in vitro behavior from their wildtype counterparts, and respond appropriately to a single dose of UV. These findings confirm that malignant transformation of CDKN2A mutant melanocytes requires additional hits, such as repetitive UV exposure, loss of p15, or somatic mutations facilitated by expression of MC1R LOF variant(s) (Robles-Espinoza et al., 2016) . It would have been very informative to compare the genome of melanoma tumors from the same mutation carriers to that of their premalignant melanocytes, but none of those carriers had a melanoma at the time of skin biopsy. Based on the reports that CDKN2A germline mutations alter global gene expression in fibroblasts and keratinocytes (Fan et al., 2013; Puig-Butille et al., 2014) , it is conceivable that these mutations, which are not exclusively melanocyte-autonomous, result in an aberrant microenvironment, which is conducive for genomic instability of melanocytes. Fortunately, we established primary keratinocyte and fibroblast cultures from the biopsies of donors listed in Table 1 .
This will enable us to conduct future experiments to determine the impact of CDKN2A mutations on the secretome of keratinocytes and fibroblasts, and to investigate the interactions of these cells with melanocytes in the context of a 3D cultured skin model. 
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